- Published on
Toxicology – Sedative–Hypnotic (Hypnosedative) Toxidrome
Sources
This toxidrome is associated with a broad group of central nervous system depressants, including alcohols, anticonvulsants, barbiturates, benzodiazepines, chloral hydrate, gamma-hydroxybutyrate (GHB), phenobarbital, meprobamate, methaqualone, muscle relaxants, tranquilizers, and sedative-hypnotic agents such as zolpidem.
Typical Presentation
Patients often present with decreased level of consciousness, ranging from drowsiness to coma. A common scenario involves combined use of substances (e.g., benzodiazepines with alcohol), leading to enhanced sedative effects. Individuals may appear intoxicated, with slurred speech, poor coordination, and impaired balance.
Clinical Features
Findings resemble alcohol intoxication and include respiratory depression, bradycardia, hypotension, ataxia, slurred speech, lethargy, disinhibition, decreased muscle tone, nystagmus, and progressive central nervous system depression. Severe cases may progress to stupor or coma. Effects are typically dose-dependent and often worsened by coingestion with alcohol. Certain agents such as GHB and methaqualone may lower the seizure threshold, while abrupt withdrawal from chronic use can lead to seizures and may be life-threatening.
Mechanism of Action
Most sedative–hypnotic agents exert their effects by enhancing gamma-aminobutyric acid (GABA) activity in the central nervous system, resulting in generalized neuronal inhibition.
Management
Treatment is primarily supportive, with attention to airway protection and hemodynamic stability. In patients with altered mental status, cervical spine precautions and neuroimaging may be necessary to exclude other causes. Endotracheal intubation should be considered in cases of compromised airway or respiratory depression. Flumazenil may be used cautiously in benzodiazepine-naïve patients, but it is generally avoided in chronic users due to the risk of precipitating severe withdrawal and seizures.
Key Points
- Alkalinization of urine can enhance elimination of certain barbiturates.
- Meprobamate toxicity may be managed with dialysis in severe cases.
0 Comments
